FDA approves gepotidacin, a first-in-class oral antibiotic, for treating uncomplicated urinary tract infections in females aged 12 and older, based on phase III trial results.
Herpes entering through the nose smells like trouble for the brain. Mangos may have a seat at the metabolic table. And humans don't understand their dogs as much as they think they do. We dive into these studies and more.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Maybe skip the Friday surgery slot to avoid risks. Study suggests we should think before getting ink. Tiny water bears see a big cancer treatment win, and more this week!
Clinical trial demonstrates combined oral and topical antimicrobial therapy for male partners reduces bacterial vaginosis recurrence by nearly half compared to standard female-only treatment, potentially changing clinical practice for a condition affecting 30% of reproductive-aged women worldwide.
Researchers found that universal hepatitis C screening guidelines increased testing rates in pregnant women, but overall uptake remained low, particularly among nonpregnant women.